DeepWork Capital

DeepWork Capital, established in 2015 and based in Orlando, Florida, is an early-stage venture capital firm. The firm primarily targets technology and life sciences startups, particularly those in U.S. regions traditionally underserved by venture capital. DeepWork Capital's investment strategy focuses on seed and Series A stage companies, often being the first institutional capital after friends, family, and angel investors. Their portfolio includes a diverse range of companies such as AbFero Pharmaceuticals, acquired by Pharmacosmos, and AireHealth, addressing respiratory challenges. Other notable investments include Astrocyte Pharmaceuticals, developing therapeutics for brain injury, and Genascence, working on gene therapy for musculoskeletal diseases. The firm also supports innovative startups like Nanophotonica, which is pioneering EL-QLED technology, and Homee, which digitizes insurance claims processes. The DeepWork Capital team, including Managing Partners Mitchel Laskey, Ben Patz, and Kathy Chiu, brings a wealth of experience from various industries. The firm emphasizes a hands-on, active engagement approach, supporting entrepreneurs before, during, and after investment. DeepWork Capital's mission is to foster innovation in regions like Florida by providing necessary capital and strategic support to tech-forward founders committed to solving significant societal challenges.